Recursion Pharmaceuticals Files 8-K on Shareholder Votes
Ticker: RXRX · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1601830
| Field | Detail |
|---|---|
| Company | Recursion Pharmaceuticals, Inc. (RXRX) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: RXRX
TL;DR
RXRX filed an 8-K about shareholder votes - details to follow.
AI Summary
Recursion Pharmaceuticals, Inc. filed an 8-K on June 18, 2025, to report on the submission of matters to a vote of its security holders. The filing does not contain details about specific proposals or outcomes of any votes.
Why It Matters
This filing indicates that Recursion Pharmaceuticals is engaging with its shareholders on important corporate matters, which could impact future strategic decisions and governance.
Risk Assessment
Risk Level: low — The filing is procedural and does not disclose new financial or operational risks.
Key Players & Entities
- RECURSION PHARMACEUTICALS, INC. (company) — Registrant
- June 18, 2025 (date) — Date of earliest event reported
- 41 S Rio Grande Street, Salt Lake City, UT 84101 (address) — Principal executive offices
FAQ
What specific matters were submitted for a vote of security holders?
The filing states that matters were submitted to a vote of security holders, but does not specify what those matters were.
When did the vote take place or when will it take place?
The filing does not specify the date of the vote, only that matters were submitted.
What was the outcome of the vote?
The filing does not disclose the outcome of any vote.
Are there any proposed changes to the company's board of directors or executive compensation?
The filing does not provide details on specific proposals, so it's unknown if these were part of the matters submitted for a vote.
Is this filing related to any specific corporate action like a merger or acquisition?
The filing is categorized under 'Submission of Matters to a Vote of Security Holders' and does not explicitly mention a merger or acquisition.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding RECURSION PHARMACEUTICALS, INC. (RXRX).